With 12 years of experience in the pharmaceutical sector, William Chen has spent half of his career with multinational companies specializing in Public Affairs and Policy, and the other half with a publicly listed biotech firm, serving as Corporate Secretary and Vice President of Investor Relations.
He brings deep expertise in government affairs, policy shaping, business development, and strategic partnerships, with a strong track record in advancing market access, managing investor communications, and driving cross-border collaborations. His background bridges both global innovation environments and China’s dynamic biotech landscape, enabling him to translate policy and business insights into actionable growth strategies.
Key strengths include:
• Government & Public Affairs Strategy
• Policy Advocacy & Stakeholder Engagement
• Corporate Governance & Capital Market Communication
• Business Development, Licensing & Deal Execution
